CELL is a premier academic journal in the field of Biochemistry, Genetics, and Molecular Biology, published by CELL PRESS. Founded in 1974, this esteemed journal has steadfastly contributed to advancing our understanding of cellular processes and organisms, making it integral for researchers and practitioners alike. With an impressive impact factor that places it in the Q1 category of its field, CELL ranks #1 out of 221 in general biochemistry and genetics, achieving a remarkable 99th percentile in Scopus rankings. Though it is not currently an open-access publication, the journal regularly disseminates high-quality research that impacts the scientific community significantly. Researchers, students, and professionals seeking to stay at the forefront of innovative discoveries and methodologies in molecular biology will find CELL an invaluable resource through its comprehensive articles and reviews.

Advances in Gerontology is a pivotal academic journal dedicated to the field of gerontology, published by PLEIADES PUBLISHING INC. With its ISSN 2079-0570 and E-ISSN 2079-0589, this journal serves as an essential platform for researchers, healthcare professionals, and students focused on aging and related health issues. Although currently not an open-access journal, it aspires to enrich the scholarly community by disseminating high-quality research from 2011 through 2024. The journal is recognized in the lower quartile of its category, ranking Q4 in both Geriatrics and Gerontology, reflecting its commitment to addressing emerging topics in the aging population despite its lower visibility in the competitive landscape. As it continues to explore critical areas in gerontology, Advances in Gerontology invites contributions that advance knowledge, foster understanding, and inform practices within this essential field of study.

BIOGERONTOLOGY, published by SPRINGER, is a premier journal dedicated to the interdisciplinary study of biological aging processes and their implications for health and longevity. With an ISSN of 1389-5729 and an E-ISSN of 1573-6768, this journal features cutting-edge research that addresses critical questions in the fields of aging, geriatrics, and gerontology. Ranking impressively in the top quartiles, particularly as Q1 in Gerontology, BIOGERONTOLOGY is recognized for its contributions to advancing the understanding of aging at both molecular and systemic levels. The journal’s rich repository of scholarly articles provides valuable insights for researchers, healthcare professionals, and students alike, fostering a deeper comprehension of age-related biological mechanisms. Although not an open-access journal, it is highly regarded with an impact factor that reflects its significant role in the academic community. The journal spans from 2000 to 2024, ensuring a broad historical context for its studies, and is based in the Netherlands, with its administrative office located at One New York Plaza, Suite 4600, New York, NY 10004, United States. Engaging with BIOGERONTOLOGY means joining a global dialogue on the science of aging and the implications it holds for humanity.

npj Aging, published by Nature Publishing Group, is a pioneering journal dedicated to advancing our understanding of the biological, clinical, and social aspects of aging. With an E-ISSN of 2731-6068, this open-access journal aims to foster innovative research and interdisciplinary dialogue among scientists, clinicians, and policy-makers. As of its inception in 2023, the journal has quickly established itself within the scholarly community, ranking 15th in Medicine (Geriatrics and Gerontology) and 12th in Biochemistry, Genetics, and Molecular Biology focusing on Aging, reflecting a strong percentile standing in both categories. The journal provides a platform for disseminating important findings that address the complexities of aging, ensuring accessibility for a broader audience. Located at the Macmillan Building, 4 Crinan St, London, England, npj Aging aspires to be an essential resource for those seeking to enhance their understanding and contribute to the field of gerontology.

Journals of Gerontology Series A: Biological Sciences and Medical Sciences, published by Oxford University Press Inc, stands at the forefront of aging research, bridging the gap between biological sciences and medical practices to address the complexities of gerontology. With an impressive impact factor reflecting its significant contribution to the field, this journal is recognized within the Q2 quartile in Aging and the Q1 quartile in Geriatrics and Gerontology for 2023, evidencing its high-quality scholarship and relevance. Researchers and professionals will find valuable insights through its comprehensive coverage of aging-related topics, informed by cutting-edge studies ranked among the top in their category—Rank #11 in Geriatrics and Gerontology and Rank #9 in Aging on Scopus. The journal aims to disseminate innovative research that can impact health care practices and enhance the quality of life in older populations. For those engaged in studies of aging, this journal offers a vital platform for sharing knowledge and advancing the understanding of biological and medical sciences as they pertain to gerontology.

EXPERIMENTAL GERONTOLOGY is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, dedicated to the evolving field of aging research. With a rich history dating back to 1964 and continuing through 2024, this journal aims to advance the understanding of the biological processes underlying aging and develop interdisciplinary approaches to improve healthspan. ENCOMPASSING a broad scope, including *biochemistry*, *cell biology*, *endocrinology*, *genetics*, and *molecular biology*, it holds impressive rankings in the 2023 Scopus Ranks, featuring in Q1 and Q2 quartiles across multiple categories. This positions it as a vital resource for researchers and professionals focused on gerontology and related fields. As a subscription-based journal without open access, EXPERIMENTAL GERONTOLOGY ensures the dissemination of high-quality research through rigorous peer review, making it an essential publication for those aspiring to remain at the forefront of aging studies.

Frontiers in Aging Neuroscience, published by FRONTIERS MEDIA SA, is a leading open-access journal dedicated to the field of aging neuroscience, with its ISSN being 1663-4365. Since its inception in 2009, this journal has provided a platform for researchers to disseminate their findings on the neurological aspects of aging, addressing critical issues that impact cognition and overall brain health in the elderly population. With a commendable 2023 impact factor, the journal ranks in the Q2 category in both Aging and Cognitive Neuroscience, positioning it among the top-tier publications in these fields. Notably, it is recognized within Scopus, ranking #32 out of 115 in Neuroscience (Cognitive Neuroscience) and #20 out of 38 in the Aging sector, with corresponding percentiles of 72nd and 48th, respectively. As an open-access journal, it promotes unrestricted access to research findings, fostering collaboration and innovation among the academic community. Researchers, professionals, and students alike can explore cutting-edge studies that contribute to understanding the complexities of neurological aging and work towards improving cognitive health in an aging society.

The Lancet Healthy Longevity is a premier journal published by Elsevier that focuses on advancing our understanding of healthy aging and longevity through interdisciplinary research. Established in 2020, this Open Access journal is committed to disseminating innovative findings that enhance public and individual health, making it accessible to a global audience. The journal is proud to be recognized with a Q1 ranking in critical categories such as Family Practice, Geriatrics and Gerontology, Health (Social Science), and Psychiatry and Mental Health, indicating its prominent role in shaping contemporary discourse in these domains. As one of the leading titles within the field, it holds an influential position in Scopus rankings, with top placements in Geriatrics and Gerontology as well as Family Practice, thereby reaching the 99th percentile of scholarly impact. The Lancet Healthy Longevity aims to foster collaboration among researchers, healthcare professionals, and policymakers to promote healthy longevity, ultimately supporting the growing aging population worldwide. With its commitment to high-quality research and global accessibility, this journal is a vital resource for those dedicated to improving health outcomes across the lifespan.

AGEING RESEARCH REVIEWS, published by Elsevier Ireland Ltd, is a prestigious academic journal dedicated to advancing our understanding of the biological, psychological, and societal aspects of aging. With an ISSN of 1568-1637 and E-ISSN of 1872-9649, this journal has established itself as a leading resource in the fields of Aging, Biochemistry, Biotechnology, Molecular Biology, and Neurology, consistently ranked in the Q1 category across these disciplines as of 2023. For researchers, students, and professionals eager to explore cutting-edge findings and innovative methodologies, AGEING RESEARCH REVIEWS gathers comprehensive reviews that facilitate a deeper understanding of age-related processes. Its high impact factor and exceptional Scopus rankings—ranking #1 in Aging and #3 in Neurology—underscore its critical role in shaping contemporary aging research. This journal not only serves as a vital reference point but also fosters a collaborative space for the scientific community focused on improving health outcomes across the life span. Published continuously since 2002 and with a converging focus through 2024, AGEING RESEARCH REVIEWS remains committed to disseminating impactful knowledge that drives progress in our understanding of the aging process.

Frontiers in Aging is a leading academic journal published by FRONTIERS MEDIA SA, dedicated to advancing the understanding of the biological processes associated with aging. Established in 2020, this open-access journal aims to bridge the gap between various disciplines including genetics, molecular biology, and physiology, providing a multidisciplinary platform for researchers and clinicians alike. With a notable impact factor denoted by its Q2 quartile rankings in Aging, Genetics, and Molecular Biology, and a Q1 ranking in Physiology as of 2023, the journal is recognized for its contribution to the scientific community. Located in Lausanne, Switzerland, it is committed to promoting open discourse and publishing cutting-edge studies that address the complexities of aging and its implications for health and longevity. The journal’s editorial board, consisting of leading experts, ensures the rigorous peer-review process, maintaining high academic standards and fostering innovation in aging research.